CClaimWatch
In litigation — no settlement yetdrugs medicalother

Boehringer Ingelheim Pharmaceuticals Antitrust Class Action

Verified October 23, 2026Found via the federal court docketHow ClaimWatch verifies cases

Still being litigated: the claims below are allegations, not findings, and there is no settlement, claim form or payout yet.

Where this case stands

In litigation

The case has been filed and is being fought in court. There is no settlement, no claim form and no payout yet; many class actions are dismissed or never certified.

Pending in the District Court, D. Massachusetts (No. 1:24-cv-10565).

  1. March 6, 2024
    Case filed

What happened

The plaintiff, a labor health and welfare fund, filed this proposed class action against Boehringer Ingelheim Pharmaceuticals, Inc., apparently alleging antitrust violations related to pharmaceutical products. The case has been consolidated into a multidistrict litigation (MDL) with other similar cases. These are allegations in a newly filed case, not proven facts and not yet a settlement.

Do you qualify?

No settlement exists yet, so there is nothing to file and no class definition to check. If the case settles, the settlement will define exactly who qualifies — watch this case and we'll let you know.

How to file

There is no claim to file yet. If this case reaches a settlement, a claim process will open — usually with an official settlement website and a filing deadline.

Common questions

Can I file a claim in the Boehringer Ingelheim Pharmaceuticals Antitrust Class Action case?
No. The case is still being litigated — there is no settlement, no claim form, and no payout. It was filed March 6, 2024 in the District Court, D. Massachusetts (No. 1:24-cv-10565).What a class action lawsuit is →
Who are the attorneys in the Boehringer Ingelheim Pharmaceuticals Antitrust Class Action?
For the plaintiffs: Sarah LaFreniere (Edelson PC); Natasha J. Fernandez-Silber (Edelson PC); Jonathan S. Crevier (DiCello Levitt LLP); Geralyn J. Trujillo (DiCello Levitt Gutzler LLC). For Boehringer Ingelheim Pharmaceuticals, Inc.: Samuel Newland Rudman (Choate, Hall & Stewart); Christopher N. Sipes (Covington & Burling); Steve B. Pet (Gibson Dunn & Crutcher LLP); Nancy Ding (Gibson, Dunn & Crutcher LLP). From the public court docket.

Who's involved

Plaintiffs

  • Massachusetts Laborers' Health & Welfare Fund

Defendants

  • Boehringer Ingelheim International GMBH
  • Boehringer Ingelheim Pharmaceuticals, Inc.

Counsel for plaintiffs

Counsel for defendants

Other cases these firms appear in

From the public court docket, contact details as filed; not an endorsement.

Guides:What is a class action lawsuit?How class membership worksYour options as a class member

Summarised from public settlement documents; confirm terms on the official settlement website. ClaimWatch is not a law firm, and filing a claim is free.

More drugs & medical settlements

View all →
November 10, 2026insurance

Anthem Brand Name Drugs Denial of Coverage Settlement

Up to $8,850

Deadline TBDdrugs medical

MSU Counseling & Mental Health Services Fund